ALL NEWS

4593 RESULTS

Sort By:

Soluble Aβ: Getting a Grip on Its Fate

In Alzheimer’s patients, a portion of soluble amyloid-β peptides (sAβ) never makes it out of the brain as in normal subjects, ending up instead in amyloid fibrils or plaques. A trio of recent papers explores factors that determine the fate of these peptides...

ALS—Is It the Neurons or the Glia?

One well-characterized cause of amyotrophic lateral sclerosis (ALS) is mutation of the copper-zinc isoform of superoxide dismutase (SOD), causing progressive degeneration of motor neurons. But must these mutations occur in neurons to be detrimental? A report in today’s Science suggests...

Gleevec for Alzheimer's?

Gleevec, the cancer "wonder drug" that has proven effective for gastrointestinal stromal tumors might also be useful for Alzheimer's patients, if only one could deliver it to the brain effectively...

Tau Kinase Mediates Stroke Damage

The September 21 online Nature Neuroscience reports that the serine-threonine kinase Cdk5, which is known to phosphorylate the neurofibrillary tangle protein tau, is essential for ischemia-provoked death of hippocampal CA1 neurons...

BACE Goes Rafting after APP

A new study adds support to the theory that a critical first step in the production of the Aβ peptide by the BACE enzyme occurs primarily in specialized, cholesterol-rich areas of the plasma membrane called "lipid rafts"...

Current Filters

  • Date Range : All x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE OF NEWS
DISEASE
TOPIC
BIOMOLECULE